持田製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/03/10 | 3,270 | 3,300 | 3,265 | 3,270 | +25 | +0.8% | 15,200 |
| 2025/03/07 | 3,280 | 3,280 | 3,220 | 3,245 | -65 | -2% | 29,100 |
| 2025/03/06 | 3,320 | 3,335 | 3,270 | 3,310 | +20 | +0.6% | 28,400 |
| 2025/03/05 | 3,250 | 3,305 | 3,240 | 3,290 | +50 | +1.5% | 37,000 |
| 2025/03/04 | 3,205 | 3,255 | 3,200 | 3,240 | +55 | +1.7% | 26,900 |
| 2025/03/03 | 3,130 | 3,185 | 3,130 | 3,185 | +55 | +1.8% | 27,300 |
| 2025/02/28 | 3,155 | 3,160 | 3,115 | 3,130 | -15 | -0.5% | 30,800 |
| 2025/02/27 | 3,150 | 3,150 | 3,120 | 3,145 | +20 | +0.6% | 20,100 |
| 2025/02/26 | 3,165 | 3,170 | 3,110 | 3,125 | -10 | -0.3% | 29,600 |
| 2025/02/25 | 3,050 | 3,160 | 3,035 | 3,135 | +80 | +2.6% | 31,200 |
| 2025/02/21 | 3,090 | 3,090 | 3,040 | 3,055 | -35 | -1.1% | 22,100 |
| 2025/02/20 | 3,150 | 3,150 | 3,090 | 3,090 | -70 | -2.2% | 32,900 |
| 2025/02/19 | 3,230 | 3,235 | 3,155 | 3,160 | -75 | -2.3% | 20,800 |
| 2025/02/18 | 3,225 | 3,260 | 3,195 | 3,235 | +10 | +0.3% | 14,500 |
| 2025/02/17 | 3,265 | 3,275 | 3,225 | 3,225 | -25 | -0.8% | 8,600 |
| 2025/02/14 | 3,260 | 3,265 | 3,220 | 3,250 | +15 | +0.5% | 14,300 |
| 2025/02/13 | 3,185 | 3,265 | 3,175 | 3,235 | +65 | +2.1% | 19,900 |
| 2025/02/12 | 3,265 | 3,275 | 3,170 | 3,170 | -50 | -1.6% | 36,600 |
| 2025/02/10 | 3,285 | 3,340 | 3,220 | 3,220 | -130 | -3.9% | 47,500 |
| 2025/02/07 | 3,310 | 3,415 | 3,290 | 3,350 | +5 | +0.1% | 23,800 |
| 2025/02/06 | 3,345 | 3,355 | 3,285 | 3,345 | +55 | +1.7% | 16,100 |
| 2025/02/05 | 3,320 | 3,340 | 3,265 | 3,290 | +5 | +0.2% | 16,100 |
| 2025/02/04 | 3,330 | 3,385 | 3,285 | 3,285 | +25 | +0.8% | 19,500 |
| 2025/02/03 | 3,315 | 3,365 | 3,250 | 3,260 | -115 | -3.4% | 45,700 |
| 2025/01/31 | 3,435 | 3,435 | 3,350 | 3,375 | -60 | -1.7% | 11,400 |
| 2025/01/30 | 3,420 | 3,450 | 3,400 | 3,435 | +15 | +0.4% | 27,900 |
| 2025/01/29 | 3,410 | 3,460 | 3,390 | 3,420 | +35 | +1% | 13,800 |
| 2025/01/28 | 3,370 | 3,420 | 3,335 | 3,385 | +15 | +0.4% | 16,800 |
| 2025/01/27 | 3,370 | 3,395 | 3,330 | 3,370 | +35 | +1% | 8,400 |
| 2025/01/24 | 3,325 | 3,385 | 3,315 | 3,335 | +10 | +0.3% | 15,700 |
| 2025/01/23 | 3,320 | 3,335 | 3,305 | 3,325 | +5 | +0.2% | 10,100 |
| 2025/01/22 | 3,315 | 3,350 | 3,295 | 3,320 | +5 | +0.2% | 12,800 |
| 2025/01/21 | 3,285 | 3,315 | 3,280 | 3,315 | +35 | +1.1% | 5,800 |
| 2025/01/20 | 3,305 | 3,315 | 3,280 | 3,280 | +5 | +0.2% | 7,300 |
| 2025/01/17 | 3,295 | 3,340 | 3,245 | 3,275 | +25 | +0.8% | 15,500 |
| 2025/01/16 | 3,330 | 3,345 | 3,250 | 3,250 | -60 | -1.8% | 15,600 |
| 2025/01/15 | 3,310 | 3,335 | 3,305 | 3,310 | -5 | -0.2% | 12,400 |
| 2025/01/14 | 3,295 | 3,355 | 3,295 | 3,315 | +15 | +0.5% | 15,500 |
| 2025/01/10 | 3,300 | 3,340 | 3,300 | 3,300 | -25 | -0.8% | 9,200 |
| 2025/01/09 | 3,355 | 3,375 | 3,325 | 3,325 | -50 | -1.5% | 20,200 |
| 2025/01/08 | 3,415 | 3,415 | 3,350 | 3,375 | -40 | -1.2% | 18,000 |
| 2025/01/07 | 3,490 | 3,490 | 3,405 | 3,415 | -30 | -0.9% | 19,600 |
| 2025/01/06 | 3,520 | 3,520 | 3,430 | 3,445 | -75 | -2.1% | 26,800 |
| 2024/12/30 | 3,580 | 3,580 | 3,505 | 3,520 | -40 | -1.1% | 14,500 |
| 2024/12/27 | 3,550 | 3,570 | 3,515 | 3,560 | +15 | +0.4% | 20,200 |
| 2024/12/26 | 3,550 | 3,550 | 3,500 | 3,545 | +35 | +1% | 29,400 |
| 2024/12/25 | 3,510 | 3,510 | 3,425 | 3,510 | +35 | +1% | 15,200 |
| 2024/12/24 | 3,515 | 3,515 | 3,445 | 3,475 | -40 | -1.1% | 7,300 |
| 2024/12/23 | 3,485 | 3,530 | 3,485 | 3,515 | +30 | +0.9% | 9,800 |
| 2024/12/20 | 3,485 | 3,540 | 3,465 | 3,485 | +10 | +0.3% | 55,400 |
51～
100
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
